Related Experiment Video
Updated: Jul 20, 2026
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Mangiferin Alleviates Postpartum Depression-Like Behaviors by Inhibiting MAPK Signaling in Microglia
Meichen Yan1, Xuena Bo1, Xinchao Zhang1
1Center on Translational Neuroscience, College of Life and Environmental Science, Minzu University of China, Beijing, China.
Abstract:
Postpartum depression (PPD), a severe mental health disorder, is closely associated with decreased gonadal hormone levels during the postpartum period. Mangiferin (MGF) possesses a wide range of pharmacological activities, including anti-inflammation. Growing evidence has suggested that neuroinflammation is involved in the development of depression. However, the role of MGF in the development of PPD is largely unknown. In the present study, by establishing a hormone-simulated pregnancy PPD mouse model, we found that the administration of MGF significantly alleviated PPD-like behaviors. Mechanistically, MGF treatment inhibited microglial activation and neuroinflammation. Moreover, we found that MGF treatment inhibited mitogen-activated protein kinase (MAPK) signaling in vivo and in vitro. Together, these results highlight an important role of MGF in microglial activation and thus give insights into the potential therapeutic strategy for PPD treatment.
Insights
Mangiferin (MGF) can alleviate postpartum depression (PPD)-like behaviors by reducing neuroinflammation and microglial activation. This study explores MGF as a potential therapeutic for PPD.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Postpartum depression (PPD) is linked to hormonal changes and neuroinflammation.
- Mangiferin (MGF) has anti-inflammatory properties, but its role in PPD is unclear.
Purpose of the Study:
- To investigate the therapeutic potential of Mangiferin (MGF) in a mouse model of postpartum depression (PPD).
- To elucidate the underlying mechanisms of MGF's action in PPD.
Main Methods:
- A hormone-simulated pregnancy PPD mouse model was established.
- MGF was administered to assess its effects on PPD-like behaviors.
- Microglial activation, neuroinflammation, and MAPK signaling were analyzed.
Main Results:
- MGF administration significantly reduced PPD-like behaviors in the mouse model.
- MGF inhibited microglial activation and suppressed neuroinflammation.
- MGF treatment downregulated mitogen-activated protein kinase (MAPK) signaling.
Conclusions:
- Mangiferin demonstrates therapeutic potential for postpartum depression.
- MGF's efficacy is mediated through the inhibition of microglial activation and neuroinflammation.
- MGF may offer a novel therapeutic strategy for PPD treatment.
